NCT04982952

Brief Summary

The prevalence of smoking in the homeless population (70%) is over 4 times that of the general population (15%). Homeless adults have not experienced similar declines in tobacco use as the general population has over the past three decades. Homeless adults are interested in smoking cessation and make quit attempts, but are less successful in quitting smoking than the general population. Trials of group behavioral counseling and pharmacotherapy for smoking cessation have not led to substantial long-term abstinence (i.e., abstinence for 6 months or more), suggesting that these interventions alone are insufficient to improve quit rates among homeless adults. Many homeless adults seek health care in safety net clinics; these clinics could bring cessation interventions to scale. Contingency management is a powerful behavior change intervention that reinforces positive health behaviors through the provision of modest incentives (e.g., cash). In this pilot randomized controlled trial, the investigator will test the feasibility and acceptability of a contingency management intervention that provides incentives for smoking cessation for people experiencing homelessness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 29, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

November 9, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

2.6 years

First QC Date

July 23, 2021

Last Update Submit

December 3, 2024

Conditions

Keywords

Contingency Management

Outcome Measures

Primary Outcomes (4)

  • Proportion of participants who achieve point prevalence abstinence

    The proportion of participants who achieve biochemically-verified 7-day point prevalence abstinence defined as participants (1) reporting not smoking a single cigarette in the past seven days, not even a puff; (2) having carbon monoxide (CO) levels \<=5 parts per million (ppm), and (3) urinary anatabine/anabasine assay levels \< 2 nanograms per milliliter (ng/ml).

    6 months

  • Median number of carbon monoxide (CO) negative samples

    The total number of negative CO specimen samples collected throughout the first 6 months of the program will be reported with 24 maximum possible number of samples per person.

    6 months

  • Median total number of counseling sessions attended

    The number of counseling sessions attended per person will will recorded with a maximum of 5 sessions total.

    6 months

  • Proportion of the sample retained as a result of retention procedures over time

    The proportion of participants who choose to attend cessation sessions visits at 2 weeks, 1 month, 3 months, 6 months, and 12 months. A participant will be considered lost to follow-up and censored on their last visits if the participants have failed to return for a scheduled visit and the study staff are unable to contact the participant after at least 3 attempts.

    Up to 12 months

Secondary Outcomes (3)

  • Proportion of participants who achieve point prevalence abstinence

    3 months

  • Proportion of participants who achieve point prevalence abstinence

    12 months

  • Proportion of participants who achieve prolonged abstinence over time

    Up to 6 months

Study Arms (2)

Contingency Management (CM)

EXPERIMENTAL

In addition to receiving usual cessation care at the Tom Waddell Urban Health Center (TWUHC), CM intervention participants with CO-verified abstinence will obtain a CM incentive payment, via gift cards and/or cash redeemable in national retail chains.

Behavioral: Contingency Management - Increasing

Control Group

OTHER

Participants who choose to attend smoking cessation in the usual care setting at TWUHC will receive a basic $5 payment for attending each study visit.

Behavioral: Fixed payments

Interventions

Increasing incentive payment for abstinent participant

Contingency Management (CM)
Fixed paymentsBEHAVIORAL

Fixed payments for attending study visits

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are 18 years or older
  • Engaged in care at the Tom Waddell Urban Health Center (TWUHC)
  • Meet criteria for homelessness as defined by the Homeless Emergency Assistance and Rapid Transition to Housing Act
  • Are current smokers (smoked at least 100 cigarettes in lifetime, smoked daily in the past 7 days and at least 5 cigarettes per day, verified by expired Carbon Monoxide (CO) \>= 8 parts per million (ppm))
  • Have an intention to quit smoking within the next six months
  • Are attending on-site smoking cessation counseling provided by the behavioral counselors
  • Are English proficient
  • Are able to provide informed consent. Patients who are interested in participating but not enrolled in counseling services will be encouraged to engage in counseling sessions at the time of enrollment.

You may not qualify if:

  • \. Are unable to take nicotine replacement therapy (e.g., pregnancy or myocardial infarction (MI) within the past 2 weeks)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Richard H. Fine's People's Clinic

San Francisco, California, 94110, United States

Location

University of California, San Francisco

San Francisco, California, 94143, United States

Location

Related Publications (1)

  • Molina MF, Hall SM, Stitzer M, Kushel M, Chakravarty D, Vijayaraghavan M. Contingency management to promote smoking cessation in people experiencing homelessness: Leveraging the electronic health record in a pilot, pragmatic randomized controlled trial. PLoS One. 2022 Dec 16;17(12):e0278870. doi: 10.1371/journal.pone.0278870. eCollection 2022.

MeSH Terms

Conditions

Smoking CessationTobacco SmokingSmoking Reduction

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorSmokingTobacco Use

Study Officials

  • Maya Vijayaraghavan, MD, MAS

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomization into one of 2 groups will be stratified by recruiter and a binary nicotine dependency code
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2021

First Posted

July 29, 2021

Study Start

November 9, 2021

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

December 5, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations